Pill imprint M 745 has been identified as Benazepril and hydrochlorothiazide 20 mg / 12.5 mg.
Benazepril/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Benazepril/hydrochlorothiazide 20 mg / 12.5 mg is not subject to the Controlled Substances Act.
See also related documents.
| Imprint(s):M 745 | Strength(s):20 mg / 12.5 mg |
| Color:Beige | Size:16.00 mm |
| Shape:Elliptical / Oval | Availability:Prescription only |
- Inactive Ingredients:
-
- lactose anhydrous
- ferric oxide black
- silicon dioxide colloidal
- crospovidone
- hypromellose
- polydextrose
- polyethylene glycol
- pregelatinized starch
- stearic acid
- magnesium silicate
- titanium dioxide
- triacetin
- ferric oxide yellow
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D – Positive evidence of risk
- CSA Schedule:
- N – Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-4745